Quarterly report · Q3

Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥20.3bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥23.9bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥17.7bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥892m2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥568m2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥1.1bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥752m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥681m2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥1.2bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥699m2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥796m2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥612m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥493m2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥830m2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥466m2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥28.8bnat 2023-12-31Cons.Assets
Total assets¥27.6bnat 2023-03-31Cons.Assets
Total assets¥26.0bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥17.9bnat 2023-12-31Cons.Liabilities
Total liabilities¥18.0bnat 2023-03-31Cons.Liabilities
Net assets / equity¥10.9bnat 2023-12-31Cons.Net assets
Net assets / equity¥9.5bnat 2023-03-31Cons.Net assets
Net assets / equity¥9.9bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥5.2bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥5.5bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥46.82023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥13.522023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥35.992022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥29.032022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥9.642022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio31.9%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio28.8%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio30.9%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 42
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥123m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥123m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31¥5m
jpcrp040300-q3r_E01813-000Injection Molding Business In Americareportable segmentrevenue2023-04-01 → 2023-12-31¥4.0bn
jpcrp040300-q3r_E01813-000Injection Molding Business In Americareportable segmentrevenue external2023-04-01 → 2023-12-31¥4.0bn
jpcrp040300-q3r_E01813-000Injection Molding Business In Americareportable segmentsegment profit2023-04-01 → 2023-12-31¥64m
jpcrp040300-q3r_E01813-000Injection Molding Business In Chinareportable segmentrevenue2023-04-01 → 2023-12-31¥448m
jpcrp040300-q3r_E01813-000Injection Molding Business In Chinareportable segmentrevenue external2023-04-01 → 2023-12-31¥356m
jpcrp040300-q3r_E01813-000Injection Molding Business In Chinareportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥92m
jpcrp040300-q3r_E01813-000Injection Molding Business In Chinareportable segmentsegment profit2023-04-01 → 2023-12-31¥3m
jpcrp040300-q3r_E01813-000Injection Molding Business In Japanreportable segmentrevenue2023-04-01 → 2023-12-31¥15.8bn
jpcrp040300-q3r_E01813-000Injection Molding Business In Japanreportable segmentrevenue external2023-04-01 → 2023-12-31¥15.7bn
jpcrp040300-q3r_E01813-000Injection Molding Business In Japanreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥31m
jpcrp040300-q3r_E01813-000Injection Molding Business In Japanreportable segmentsegment profit2023-04-01 → 2023-12-31¥644m
jpcrp040300-q3r_E01813-000Real Estate Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥213m
jpcrp040300-q3r_E01813-000Real Estate Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥213m
jpcrp040300-q3r_E01813-000Real Estate Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥173m
—segment totalrevenue2023-04-01 → 2023-12-31¥20.4bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥20.3bn
—segment totalrevenue intersegment2023-04-01 → 2023-12-31¥123m
—segment totalsegment profit2023-04-01 → 2023-12-31¥887m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥68m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥68m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31¥5m
jpcrp040300-q3r_E01813-000Injection Molding Business In Americareportable segmentrevenue2022-04-01 → 2022-12-31¥2.4bn
jpcrp040300-q3r_E01813-000Injection Molding Business In Americareportable segmentrevenue external2022-04-01 → 2022-12-31¥2.4bn
jpcrp040300-q3r_E01813-000Injection Molding Business In Americareportable segmentsegment profit2022-04-01 → 2022-12-31−¥38m
jpcrp040300-q3r_E01813-000Injection Molding Business In Chinareportable segmentrevenue2022-04-01 → 2022-12-31¥633m
jpcrp040300-q3r_E01813-000Injection Molding Business In Chinareportable segmentrevenue external2022-04-01 → 2022-12-31¥592m
jpcrp040300-q3r_E01813-000Injection Molding Business In Chinareportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥40m
jpcrp040300-q3r_E01813-000Injection Molding Business In Chinareportable segmentsegment profit2022-04-01 → 2022-12-31¥83m
jpcrp040300-q3r_E01813-000Injection Molding Business In Japanreportable segmentrevenue2022-04-01 → 2022-12-31¥14.5bn
jpcrp040300-q3r_E01813-000Injection Molding Business In Japanreportable segmentrevenue external2022-04-01 → 2022-12-31¥14.5bn
jpcrp040300-q3r_E01813-000Injection Molding Business In Japanreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥27m
jpcrp040300-q3r_E01813-000Injection Molding Business In Japanreportable segmentsegment profit2022-04-01 → 2022-12-31¥342m
jpcrp040300-q3r_E01813-000Real Estate Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥215m
jpcrp040300-q3r_E01813-000Real Estate Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥215m
jpcrp040300-q3r_E01813-000Real Estate Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥175m
—segment totalrevenue2022-04-01 → 2022-12-31¥17.7bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥17.7bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥68m
—segment totalsegment profit2022-04-01 → 2022-12-31¥562m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 347
ItemContextValueUnit
Report amendment flagFilingDateInstantfalse
Xbrl amendment flagFilingDateInstantfalse
Business results of group (text)FilingDateInstantText · Plus
Description of business (text)FilingDateInstantText · Plus
Business risks (text)FilingDateInstantText · Plus
Management analysis of financial position operating results and cash flows (text)FilingDateInstantText · Plus
Critical contracts for operation (text)FilingDateInstantText · Plus
Total number of shares (text)FilingDateInstantText · Plus
Issued shares total number of shares etc (text)FilingDateInstantText · Plus
Class issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)普通株式
Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registeredFilingDateInstant_OrdinaryShareMember
Original text (Japanese)東京証券取引所スタンダード市場
Description issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)単元株式数は、100株であります。
Details of employee share option program (text)FilingDateInstantText · Plus
Other information on share acquisition rights (text)FilingDateInstantText · Plus
Exercises etc of moving strike convertible bonds etc (text)FilingDateInstantText · Plus
Changes in number of issued shares stated capital etc (text)FilingDateInstantText · Plus
Major shareholders (text)FilingDateInstantText · Plus
Voting rights (text)FilingDateInstantText · Plus
Issued shares voting rights (text)FilingDateInstantText · Plus
Description issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithFullVotingRightsOtherMember
Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式
Description issued shares voting rightsCurrentQuarterInstant_SharesLessThanOneUnitMember
Original text (Japanese)同上
Treasury shares etc (text)FilingDateInstantText · Plus
Information about officers (text)FilingDateInstantText · Plus
Regulations in accordance with which consolidated financial statements have been prepared financial informationCurrentYTDDurationText · Plus
Note on independent audit financial informationCurrentYTDDurationText · Plus
Quarterly consolidated balance sheet (text)CurrentYTDDurationText · Plus
Year to quarter end consolidated statement of income (text)CurrentYTDDurationText · Plus
Year to quarter end consolidated statement of comprehensive income (text)CurrentYTDDurationText · Plus
Notes accounting treatments specific to quarterly financial statements quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes regarding promissory notes due on balance sheet date (text)CurrentQuarterInstantText · Plus
Description of fact that quarterly statement of cash flows has not been prepared (text)CurrentYTDDurationText · Plus
Notes regarding dividend (text)Prior1YTDDurationText · Plus
Notes regarding dividend (text)CurrentYTDDurationText · Plus
Notes segment information etc quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Footnotes regarding segment information table (text)Prior1YTDDurationText · Plus
Information about assets for each reportable segment (text)Prior1YTDDurationText · Plus
Information about impairment loss of non current assets or goodwill etc for each reportable segment (text)Prior1YTDDurationText · Plus
Footnotes regarding segment information table (text)CurrentYTDDurationText · Plus
Information about impairment loss of non current assets or goodwill etc for each reportable segment (text)CurrentYTDDurationText · Plus
Notes revenue recognition quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes per share information quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Other information consolidated financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass